AlphaRx, Inc. (ALRX.OB) Selects Hong Kong for Its Corporate Headquarters and Shanghai for an R&D Facility
AlphaRx, Inc., a specialty pharmaceutical company, recently announced that the company has selected Hong Kong as the new corporate headquarters. The company also selected a location in Shanghai for a new R&D facility. This announcement will not affect the company’s presence in Toronto, Canada, which will continue to serve as AlphaRx’s headquarters in North America. Spearheading a major push into Greater China, AlphaRx’s new R&D facility will be located in China’s Medicine Valley, a 740-acre high-tech park with more than 400 research-based companies, including the regional headquarters of some of the world’s leading pharmaceutical companies. Michael Lee, chief executive officer…